TY  - GEN
AU  - Milowsky,Matthew I
AU  - Dittrich,Christian
AU  - Durán,Ignacio
AU  - Jagdev,Satinder
AU  - Millard,Frederick E
AU  - Sweeney,Christopher J
AU  - Bajorin,Dean
AU  - Cerbone,Linda
AU  - Quinn,David I
AU  - Stadler,Walter M
AU  - Rosenberg,Jonathan E
AU  - Lochheed,Melissa
AU  - Sen,Paramita
AU  - Squires,Matthew
AU  - Shi,Michael
AU  - Sternberg,Cora N
TI  - Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma
SN  - 1879-0852
PY  - 2015///0127
KW  - Administration, Oral
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Benzimidazoles
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - genetics
KW  - Neoplasm Metastasis
KW  - Quinolones
KW  - Receptor, Fibroblast Growth Factor, Type 3
KW  - Treatment Outcome
KW  - Urologic Neoplasms
KW  - drug therapy
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ejca.2014.10.013
ER  -